{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Weeki Wachee",
      "address_1": "8265 Commercial Way",
      "reason_for_recall": "Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.",
      "address_2": "",
      "product_quantity": "1610 syringes",
      "code_info": "Lot # NEO071317MMDSA BUD: 01/19/2018  Lot # NEO071317MMDSC BUD: 01/19/2018  Lot # NEO071317MMDSF BUD: 01/19/2018",
      "center_classification_date": "20171221",
      "distribution_pattern": "Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida",
      "state": "FL",
      "product_description": "Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613,  NDC# 69623-234-15",
      "report_date": "20171227",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Premier Pharmacy Labs Inc",
      "recall_number": "D-0129-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "77979",
      "termination_date": "20180329",
      "more_code_info": "",
      "recall_initiation_date": "20170810",
      "postal_code": "34613-4511",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}